Fox 5 San Diego interviews Dr. Tom Schwieterman of Midmark on sleep apnea and the smallest, lightest home testing device in the market.
The FDA-cleared, physician-prescribed SleepView® provides a convenient and cost-effective alternative for diagnosing the most common type of breathing-related sleep disorder
Cleveland, OH - October 17, 2011 - Midmark Corporation, a trusted leader in digital diagnostic devices for ambulatory care, announced a partnership with Cleveland Medical Devices, a leader in sleep diagnostics technology, launching the Midmark SleepView® Monitor and SleepViewSM Portal.
The Midmark SleepView Monitor developed by Cleveland Medical Devices is the market’s smallest and lightest portable home sleep monitor that meets the American Academy of Sleep Medicine’s recommended channel set for Type III monitors.
The Midmark SleepView Portal offers prescribing physicians secure, HIPAA compliant online access to registered polysomnographic technologists and board-certified sleep physicians who provide scoring, professional interpretation and treatment recommendations.
Obstructive sleep apnea (OSA) is a repeated interruption of normal breathing during sleep due to a collapse of the upper airway. It is estimated to impact as many people as asthma and diabetes; yet, 85 percent of the population with the disease is undiagnosed and untreated. "There is a real need in the healthcare industry to address this large and growing clinical concern," said Tom Treon, senior product manager for Midmark. "We want to improve the effectiveness and efficiency of care for patients with OSA by providing another diagnostic option, which enables patients to be tested in the comfort of their own bed and convenience of their own home for a more natural night of sleep."
OSA does in fact hold serious health and economic consequences. Numerous studies link OSA to major chronic diseases such as stroke, heart failure, diabetes, obesity, hypertension and increased odds of serious car crash injuries. Economic studies have also shown that people with untreated OSA have 200 percent higher healthcare costs than similar people without OSA.
Midmark has entered into a strategic partnership with Cleveland Medical Devices Inc. (CleveMed) for licensing of the SleepView technology. Established in 1990, CleveMed is a leader in sleep diagnostics technology with products serving sleep labs, institutional and home settings.
Dr. Anne Eiting Klamar, President and CEO of Midmark stated, "We are very pleased to partner with CleveMed, a company that provides proven expertise in sleep disorders research and diagnostics. SleepView offers both an exciting addition to our diagnostic device portfolio and sophisticated, yet easy-to use services for our customers with the goal of providing efficient and effective patient care."
"We are very excited about our relationship with Midmark to extend sleep healthcare to patients in need", said Hani Kayyali, president of CleveMed. "Midmark is a strong and trusted brand with outstanding relationships among distribution and physicians. They offer our technology unique advantage to realizing the goal of providing patients, providers and payers with a convenient, cost-effective and high-quality solution to identifying OSA so it can be managed effectively."
For more information, please visit www.midmarksleepview.com, call 1-800-MIDMARK or contact your authorized Midmark distributor representative.
About CleveMed
SleepView is a registered trademark of and manufactured by Cleveland Medical Devices Inc. of Cleveland, OH. CleveMed develops innovative biomedical devices, and is a leader in miniaturized wireless telemetry and physiological monitoring devices. CleveMed has developed a growing range of products that address the needs of those with sleep disorders, including the Crystal Monitor PSG series, Sapphire, SleepScout, iPSG and DreamPort. CleveMed’s wireless sleep products allow sleep studies to be conducted remotely, and monitor a wide range of sleep disorder symptoms, while eliminating the need for typically bulky sleep diagnostic equipment. For more information, please visit www.CleveMed.com (Follow us on CleveMed Blogs, twitter, youtube, LinkedIn, and facebook)
About Midmark Medical
Dedicated to helping healthcare providers deliver the most efficient patient care, Midmark is redefining the future of the clinical space from the examination room to the procedure room, providing clinical solutions to redefine workflow. Its line of Midmark and Ritter Barrier-Free® examination and procedures tables, diagnostic products, sterilizers, lighting, seating and casework have become the industry standards in medical practices of all sizes, helping improve the patient experience while improving safety, ergonomics, productivity and profitability. Midmark’s IQ Digital Diagnostics System, a combination of digital diagnostic devices and software solutions, allow fast and easy capture, interpretation and retrieval of patient information for single practitioners to large physician groups integrating EHR/EMRs. In addition, Midmark’s partnership with Mortara Instrument, Inc. provides a comprehensive range of ECG solutions for the U.S. and Canada ambulatory care markets. Its Care Exchange™ Workstations help physicians’ offices easily integrate IT with digital diagnostics and electronic prescriptions. For more information, visit midmarkclinicalsolutions.com or midmark.com.
For More Information Contact:
Amy Rickard
Cleveland Medical Devices Inc.
P: 216.791.6720
arickard@clevemed.com
www.clevemed.com
The diagnosis and treatment of Obstructive Sleep Apnea (OSA) is undergoing a paradigm shift particularly regarding home sleep testing (HST). Supported by many organizations like the American Academy of Sleep Medicine (AASM)1 and many insurance companies, home sleep assessment is witnessing great adoption by practitioners and patients alike as it can facilitate easier access to specialized care and improve patient quality of life.
There are a number of portable monitors that can be used in HST (as a baseline evaluation, or to evaluate the efficacy of OSA treatment whether it is OA, CPAP, or others). It is important that a facility select the right HST monitor from all the available options. Hence some of the important criteria to watch for while selecting a portable sleep monitor for your practice are:
Per the American Academy of Sleep Medicine (AASM) clinical guidelines, the proper OSA evaluation requires portable monitoring that records at least:
Other parameters that are strongly recommended are snore, temperature-based airflow (thermistor) for apnea confirmation and body position for positional apnea estimation. Some devices also record muscle activity (EMG channel), which could be of particular help to dentists during OA titration since it can evaluate bruxism.
Clearly, a system that is small, light and allows for easy self-administration of the sleep test in the home is preferred, as it avoids a sleep technologist from having to go to the patient’s house, saving time and money. Typically hook-up of sensors in HST will require: Wrapping a RIP belt around the chest, placing and securing a pulse ox on the patient’s index finger, and wearing a nasal cannula. This is only minimally invasive and painless. Sometimes a thermistor may be used along with the nasal cannula to confirm apneas.
Ease of use and data quality are doubly assured if the portable sleep monitor is designed with checks in place to indicate proper placement of the sensors (some monitors have light and others have sound indicators). Additionally, a monitor that includes an automatic check for validity of prior night sleep data would be particularly helpful as it can afford a fast way to repeat the study if needed (maybe due to a disconnected sensor). Selecting a monitor with a pre-programmed ON/OFF time can ensure proper data recording even if the patient forgets to hit the start button.
In summary, choosing the right portable sleep monitor that offers ease of use for the patient, and appropriate physiological data for the physician’s facility, while using sleep lab methodology, is the first step in deploying Home Sleep Testing the right way.
Cleveland, OH - March 23, 2011 - Cleveland Medical Devices Inc. (CMDI) has announced the formation of Great Lakes NeuroTech (www.GLNeuroTech.com), a spin-off company which has acquired the rights to develop, market, and manufacture clinical motor assessment and therapy systems for the movement disorders market as well as physiological monitors for research and education markets. Great Lakes NeuroTech (GLN) will perform R&D, engineering, manufacturing, distribution, and exporting of these technologies through two divisions: Movement Disorders and Research & Education Systems.
“Cleveland Medical Devices Inc. has been growing significantly in the areas of Sleep Disorders, Movement Disorders and Research / Education products. The spin-off will allow CMDI and GLN to further focus their efforts on their core competencies and dramatically boost their commercialization efforts”, said Robert Schmidt, CMDI’s Chairman. “The portability, quality, and cost efficacy of CMDI’s sleep monitoring products and web technologies such as SleepView, eCrytsal PSG, and Sapphire are leading the future of sleep medicine. This spin off will allow CMDI to quickly expand its market presence nationally and worldwide while continuing its excellence in R&D to serve the needs of more than 40 million sleep disorders patients”, said Robert Schmidt.
“The launch of Great Lakes NeuroTech transitions a proven line of innovative medical and research systems, an expert team of engineers and researchers, and high quality manufacturing to a new organization with a focus on these core technologies” said Joseph P. Giuffrida, PhD, GLN’s President. “The transition of technologies, marketing and manufacturing for the movement disorders and research & education product lines from CMDI to GLN is expected to occur in stages over the next few months with no interruption in quality, delivery and support to CMDI or GLN.”
GLN’s Division of Movement Disorders will target Parkinson’s disease and other movement disorders through a portfolio of patient-centered diagnostic and therapy systems integrated with wireless, remote, and web based technologies. Devices to be manufactured by GLN will include KinetiSense™, Kinesia™, and Kinesia HomeView™ systems for capturing movement disorder motor symptoms both in the clinic, at home, and during clinical trials. GLN will continue to grow the product portfolio through ongoing research and development funded by the National Institutes of Health in collaboration with key clinical opinion leaders in the field of movement disorders.
GLN’s Division of Research & Education Systems will market and manufacture a line of wireless physiological monitors and intelligent analysis software targeted to research and education markets. The BioRadio™ is a general purpose physiological monitor for capturing signals such as brain waves, muscle forces and activity, electrical heart activity, respiration, galvanic skin resistance, and pulse oximetry. The BioRadio is packaged in CleveLabs™, a lab course system with sessions for teaching physiology, psychology, health sciences, and biomedical engineering principles; and BioCapture™, a general purpose physiological research system. GLN will continue to expand the growing customer base for these technologies at universities and research institutes both domestically and internationally.
Cleveland Medical Devices Inc.’s mission is to develop, manufacture, and market innovative sleep disorders diagnostic and therapy products that improve the quality of life and reduce total health care costs for patients around the world.
Great Lakes NeuroTech is committed to pioneering innovative biomedical technologies to serve research, education, and medical communities, improving access to medical technology for diverse populations, and positively impacting quality of life for people around the world.
Maureen Phillips
Sales & Marketing Manager
216.619.5918
mphillips@GLNeuroTech.com
KinetiSense, Kinesia, Kinesia HomeView, BioRadio, CleveLabs, and BioCapture are trademarks of Cleveland Medical Devices Inc. of Cleveland OH provided under license to Great Lakes NeuroTech.